A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease
Condition:   Anemia, Sickle CellInterventions:   Drug: Aes-103;   Drug: Aes-103;   Drug: Aes-103;   Drug: Aes-103;   Drug: PlaceboSponsors:   AesRx, LLC;   AesRx, LLC;   Cato Research;   ClinPharm Consulting, LLC;   Infrared Imaging and Thermometry Unit, Biomedical Engineering and Physical Science Shared Resource (NIBIB);   National Chung Cheng University;   National Heart, Lung, and Blood Institute (NHLBI);   Therapeutics for Rare and Neglected Diseases (TRND);   QS Pharma;   Ricerca Biosciences LLC;   SAIC-Frederick, Inc.Completed - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2012 Category: Research Source Type: clinical trials

A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease
Condition:   Anemia, Sickle CellInterventions:   Drug: Aes-103;   Drug: Aes-103;   Drug: Aes-103;   Drug: Aes-103;   Drug: PlaceboSponsors:   AesRx, LLC;   AesRx, LLC;   Cato Research;   ClinPharm Consulting, LLC;   Infrared Imaging and Thermometry Unit, Biomedical Engineering and Physical Science Shared Resource (NIBIB);   National Chung Cheng University;   National Heart, Lung, and Blood Institute (NHLBI);   Therapeutics for Rare and Neglected Diseases (TRND);   QS Pharma;   Ricerca Biosciences LLC;   SAIC-Frederick, Inc.Recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2012 Category: Research Source Type: clinical trials